PURIFICATION AND USE OF THE C2D SUBUNIT OF C3.MOORE JA; MICHAEL JM; CHAPLIN H et al.1976; TRANSFUSION; U.S.A.; DA. 1976; VOL. 16; NO 3; PP. 200-208; BIBL. 21 REF.Article

COMPARISON OF LOW-MOLECULAR-WEIGHT PRODUCTS FOLLOWING REACTION OF C3-C3B WITH C3B INACTIVATOR AND WITH TRYPSIN.FREEDMAN J; CHAPLIN H; JOHNSON CA et al.1977; VOX SANG.; SUISSE; DA. 1977; VOL. 33; NO 4; PP. 212-220; BIBL. 17 REF.Article

PREPARATION OF RED CELLS COATED WITH C4 AND C3 SUBCOMPONENTS AND PRODUCTION OF ANTI-C4D AND ANTI-C3DFREEDMAN J; MOLLISON PL.1976; VOX SANG; SUISSE; DA. 1976; VOL. 31; NO 4; PP. 241-257; BIBL. 1 P. 1/2Article

EVIDENCE FOR MACROPHAGE C3D-RECEPTOR ACTIVE IN PHAGOCYTOSISWELLEK B; HAHN HH; OPFERKUCH W et al.1975; J. IMMUNOL.; U.S.A.; DA. 1975; VOL. 114; NO 5; PP. 1643-1645; BIBL. 12REF.Article

RECEPTOR-BINDING SITES ON C3 AND C3B.DIERICH MP; BOKISCH VA.1977; J. IMMUNOL.; G.B.; DA. 1977; VOL. 118; NO 6; PP. 2145-2150; BIBL. 35 REF.Article

C3B AND C3D RECEPTOR SITES ON HUMAN FIBROBLASTS DERIVED FROM SEVERAL HUMAN TISSUES.UEKI A; FUKUSHIMA Y; HYODOH F et al.1978; VIRCHOWS ARCH., B; DTSCH.; DA. 1978; VOL. 27; NO 2; PP. 155-157; BIBL. 4 REF.Article

INTERET DU DOSAGE DU C3D ET DE L'ACTIVITE HEMOLYTIQUE DU C4 (C4H) AU COURS DU LUPUS ERYTHEMATEUX DISSEMINESANTORO F; VANHILLE P; DUQUESNOY B et al.1980; REV. MED. INTERNE; FRA; DA. 1980; VOL. 1; NO 1; PP. 21-27; ABS. ENG; BIBL. 17 REF.Article

IDENTIFICATION OF A C4 SUBCOMPONENT ON C3D-COATED ERYTHROCYTES.MICHAEL JM; MOORE JA; CHAPLIN H JR et al.1976; TRANSFUSION; U.S.A.; DA. 1976; VOL. 16; NO 5; PP. 408-416; BIBL. 23 REF.Article

Functional and antigenic properties of complement receptor type 2, CR2MITOMO, K; FUJITA, T; IIDA, K et al.The Journal of experimental medicine. 1987, Vol 165, Num 5, pp 1424-1429, issn 0022-1007Article

C3 degradation products (C3d) in normal pregnancyJENKINS, J. S; POWELL, R. J.Journal of clinical pathology. 1987, Vol 40, Num 11, pp 1362-1363, issn 0021-9746Article

MATURATION-LINKED EXPRESSION OF C3B AND C3B' RECEPTORS ON DEVELOPING HUMAN BONE MARROW AND PERIPHERAL BLOOD GRANULOCYTESSCOTT CS.1981; CLIN. EXP. IMMUNOL.; ISSN 0009-9104; GBR; DA. 1981; VOL. 44; NO 1; PP. 201-210; BIBL. 25 REF.Article

INHIBITION OF LYMPHOCYTE BLASTOGENESIS BY C3C DAN C3DSCHENKEIN HA; GENCO RJ.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 122; NO 3; PP. 1126-1133; BIBL. 49 REF.Article

Demonstration of C3d and the terminal complement complex on thymic large granular lymphocytes and common thymocytes after incubation with naturally thymocytotoxic serumSANDBERG, G; STENWINKEL, C; MOLLNES, T. E et al.International archives of allergy and applied immunology. 1988, Vol 87, Num 3, pp 239-246, issn 0020-5915Article

Structures et fonctions des récepteurs pour le C3, le troisième composant du complément, présents à la surface de cellules humaines = Structures and functions of the receptor for the third component of complement, C3, expressed or human cell surfaceFRADE, R.Transactions of the Zoological Society of London. 1985, Vol 33, Num 9, pp 869-872, issn 0084-5620Article

C3d,g in normal human epidermal basement membraneBASSET-SEGUIN, N; YANCEY, K. B; JUHLIN, L et al.Acta dermato-venereologica. 1990, Vol 70, Num 3, issn 0001-5555, p. 273Article

Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3VIK, D. P; FEARON, D. T.The Journal of immunology (1950). 1985, Vol 134, Num 4, pp 2571-2579, issn 0022-1767Article

The quantitation of C3d by routine methods after the direct absorption of human plasma with anti-C3cMLYNEK, Z; NILSSON, M.Acta pathologica, microbiologica et immunologica Scandinavica. Section C. Immunology. 1985, Vol 93, Num 5, pp 195-198, issn 0108-0202Article

C3d deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcomeKUYPERS, Dirk R. J; LERUT, Evelyne; EVENEPOEL, Pieter et al.Transplantation. 2003, Vol 76, Num 1, pp 102-108, issn 0041-1337, 7 p.Article

Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutininWATANABE, Izumi; ROSS, Ted M; HASEGAWA, Hideki et al.Vaccine. 2003, Vol 21, Num 31, pp 4532-4538, issn 0264-410X, 7 p.Article

Cellular distribution of complement receptor type 4 (CR4): expression on human plateletsVIK, D. P; FEARON, D. T.The Journal of immunology (1950). 1987, Vol 138, Num 1, pp 254-258, issn 0022-1767Article

Epitope specificities and quantitative and serologic aspects of monoclonal complement (C3c and C3d) antibodiesDOBBIE, D; BRAZIER, D. M; GARDNER, B et al.Transfusion (Philadelphia, PA). 1987, Vol 27, Num 6, pp 453-459, issn 0041-1132Article

Detection of a neoantigen on human C3bi and C3d by monoclonal antibodyTAMERIUS, J. D; PANGBURN, M. K; MULLER-EBERHARD, H. J et al.The Journal of immunology (1950). 1985, Vol 135, Num 3, pp 2015-2019, issn 0022-1767Article

Complement C3 fragments in urine: detection in systemic lupus erythematosus patients by western blottingKELLY, R. H; CARPENTER, A. B; SUDOL, K. S et al.Applied and theoretical electrophoresis. 1993, Vol 3, Num 6, pp 265-289, issn 0954-6642Article

ELISA methods for the estimation of C3d. ReplySENALDI, G; PEAKMAN, M; VERGANI, D et al.Journal of immunological methods. 1989, Vol 124, Num 2, pp 283-286, issn 0022-1759Article

OKB7, a monoclonal antibody that reacts at or near the C3d binding site of human CR2RAO, P. E; WRIGHT, S. D; WESTBERG, E. F et al.Cellular immunology (Print). 1985, Vol 93, Num 2, pp 549-555, issn 0008-8749Article